Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadolol and isosorbide mononitrate with or without endoscopic banding ligation for prevention of variceal rebleeding
ISRCTN26221020Phase 4Completed
- Sponsor
- Individual sponsor
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nadolol and isosorbide mononitrate in Cirrhosis, esophageal varices and Gastroesophageal varices (GEV) (2 arms), sponsored by Individual sponsor. Primary endpoint: Rebleeding from any source. Started Feb 2003; status: completed.
02
Drugs
nadololisosorbide mononitrate
03
Conditions
Cirrhosisesophageal varicesGastroesophageal varices (GEV)
Beyond the preview
Go deeper on ISRCTN26221020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26221020.